PumasAI worked with us with incredible flexibility and agility despite tight timelines and sometimes the need for re-work or additional evaluation, as often is the case with data driven exercises.

Samira Merali, PharmD, MS,
Sr. Director & Cardiovascular Therapeutic Head,

BMS

We are impressed by the quality and breadth of the experience of PumasAI scientists in collaborating with us on modeling and simulation projects across our pipeline spanning investigational therapeutics and vaccines at various stages of clinical development.​

Husain A. PhD,
Director, Head of Clinical Pharmacology
and Pharmacometrics,

Moderna Therapeutics

...The collaboration spans across the continuum of the drug development cycle, Clinical Development, Clinical Pharmacology, Pharmacometrics, Regulatory, and Strategy. One of these collaborations for a cardio-renal asset, has resulted in a precedent-setting registration pathway where the conventional approach was not viable...

Arash Raoufinia, MS, PharmD,
VP Head of Early Phase Development
and Translational Medicine,

Otsuka Pharmaceutical Companies (U.S.)

We have a high priority oncology drug development portfolio at our company. PumasAI provided us with high quality MIDD work product which supported regulatory submissions in a timely manner. It is a pleasure to work with PumasAI scientists, and we highly recommend them!

Balaji Agoram, PhD,
VP & Head of Clinical Pharmacology,

Arcus Biosciences

PumasAI is a valued partner and works very hard to help us achieve our goal. I would recommend PumasAI highly.

Jinshan Shen, PhD,
VP & Head of Clinical Pharmacology,

Relay Therapeutics

PumasAI worked with us with incredible flexibility and agility despite tight timelines and sometimes the need for re-work or additional evaluation, as often is the case with data driven exercises.

Samira Merali, PharmD, MS,
Sr. Director & Cardiovascular Therapeutic Head,

BMS

We are impressed by the quality and breadth of the experience of PumasAI scientists in collaborating with us on modeling and simulation projects across our pipeline spanning investigational therapeutics and vaccines at various stages of clinical development.​

Husain A. PhD,
Director, Head of Clinical Pharmacology
and Pharmacometrics,

Moderna Therapeutics

...The collaboration spans across the continuum of the drug development cycle, Clinical Development, Clinical Pharmacology, Pharmacometrics, Regulatory, and Strategy. One of these collaborations for a cardio-renal asset, has resulted in a precedent-setting registration pathway where the conventional approach was not viable...

Arash Raoufinia, MS, PharmD,
VP Head of Early Phase Development
and Translational Medicine,

Otsuka Pharmaceutical Companies (U.S.)